The facility in Creedmoor produces tubing for intravenous pumps, according to the report. The production at the facility will be consolidated to existing facilities, with assembly jobs moving to Tijuana and Nogales, Mexico, while molding work will move to Sandy, Utah.
The decision to close the location was reportedly based on increasing efficiency, and not on plant performance.
“Decisions like these that affect our employees are never easy and are not taken lightly,” company spokesperson Troy Kirkpatrick told The News & Observer. “It made more sense for us to use some of our excess capacity in our other plants.”
Employees at the facility were informed of the closure in July, with layoffs taking place over 12 months beginning in April and ending in March 2018.
B.D. originally acquired the facility in its $12.2 billion purchase of CareFusion in 2014. The company employs approximately 475 individuals in North Carolina, including 215 engineering employees at its Research Triangle Park facility, according to The News & Observer report.
In September, BD said it is investing $40.4 million (EU €36 million) to expand production equipment at its Drogheda, Ireland facility, adding an additional 20 jobs.
The Franklin Lakes, N.J.-based company’s Drogheda facility produces BD PosiFlush syringes and safety components designed for insulin injection. The $40.4 million investment will allow for 2 new production lines at the plant, with the 1st manufacturing line having already commenced production.